Drug cocktails for effective treatment of glioblastoma multiforme

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

Dr Waldemar Debinski is a consulting scientific advisor and a shareholder in Targepeutics, Inc. Dr Debinski is an inventor on the patent applications submitted or issued, which are also on the subject of this paper (however, Penn State University and Wake Forest University own the patents). Dr Debinski’s work has never been supported by any industrial entity. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.